Lipella Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch LIPO and buy or sell other stocks, ETFs, and their options commission-free!

About LIPO

Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. 

CEO
Jonathan Kaufman
CEOJonathan Kaufman
Employees
7
Employees7
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2005
Founded2005
Employees
7
Employees7

LIPO Key Statistics

Market cap
10.54M
Market cap10.54M
Price-Earnings ratio
-3.97
Price-Earnings ratio-3.97
Dividend yield
Dividend yield
Average volume
434.56K
Average volume434.56K
High today
$1.75
High today$1.75
Low today
$0.93
Low today$0.93
Open price
$1.75
Open price$1.75
Volume
47.95K
Volume47.95K
52 Week high
$1.75
52 Week high$1.75
52 Week low
$0.2804
52 Week low$0.2804

People also own

Based on the portfolios of people who own LIPO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.